You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Litigation Details for Acerta Pharma B.V. v. Alembic Pharmaceuticals Limited (D. Del. 2022)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Acerta Pharma B.V. v. Alembic Pharmaceuticals Limited
The small molecule drug covered by the patents cited in this case is ⤷  Try a Trial .
Biologic Drugs cited in Acerta Pharma B.V. v. Alembic Pharmaceuticals Limited

The biologic drugs covered by the patents cited in this case are ⤷  Try a Trial , ⤷  Try a Trial , ⤷  Try a Trial , ⤷  Try a Trial , and ⤷  Try a Trial .

Details for Acerta Pharma B.V. v. Alembic Pharmaceuticals Limited (D. Del. 2022)

Date Filed Document No. Description Snippet Link To Document
2023-03-27 Construction for U.S. Patent Nos. 9,758,524; 10,239,883; 9,796,721; 10,167,291; 10,272,083 filed by AstraZeneca… 2 February 2022 1:22-cv-00154 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2022-03-25 15 Stipulation-General (See Motion List for Stipulation to Extend Time) Dismissing Claims Regarding U.S. Patent Nos. 9,758,524; 10,239,883; and 10,272,083 Without Prejudice … 2 February 2022 1:22-cv-00154 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2022-03-28 16 Order Proposed Order Claims Regarding U.S. Patent Nos. 9,758,524; 10,239,883; and 10,272,083 Without Prejudice.… 2 February 2022 1:22-cv-00154 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2022-02-02 4 Patent/Trademark Report to Commissioner of Patents 10,239,883 ;9,796,721 ;10,167,291 ;10,272,083. (mal) (Entered: 02/02/2022) 2 February 2022 PACER… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,758,524 ;10,… 2 February 2022 1:22-cv-00154 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2022-09-23 60 Stipulation-General (See Motion List for Stipulation to Extend Time) Claims Against Cipla Regarding U.S. Patent Nos. 9,758,524 and 10,239,883 Without Prejudice by AstraZeneca… 2 February 2022 1:22-cv-00154 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2023-03-13 89 Stipulation-General (See Motion List for Stipulation to Extend Time) Construction for U.S. Patent Nos. 9,758,524; 10,239,883; 9,796,721; 10,167,291; 10,272,083 by Acerta … 2 February 2022 1:22-cv-00154 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.